GlassScriptPhysician profile
Brian Inouye
NPI 1467871178
$56,966.27
in general payments reported to CMS, 2019-2025
14 companies · $5,519 in 2025
The $5,519 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $50K · 2021: $559 · 2022: $336 · 2023: $210 · 2024: $342 · 2025: $5,519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $2,000 · Food and Beverage: $1,645 · Travel and Lodging: $1,526 · Consulting Fee: $800 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $2,000.00 |
| Food and Beverage | $1,645.26 |
| Travel and Lodging | $1,525.71 |
| Consulting Fee | $800.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $53,457.96 | 2020-2025 | General - Erectile Dysfunction, Ams 700, Ams 800 Artificial Urinary Sphincter |
| Uromedica, Incorporated | $1,525.71 | 2025 | Proact |
| Laborie Medical Technologies Corp. | $923.20 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $368.93 | 2021-2025 | |
| Janssen Biotech, INC. | $210.09 | 2025 | Carvykti, Rybrevant, Erleada |
| Astellas Pharma US INC | $199.98 | 2021-2023 | |
| Baxter Healthcare | $107.95 | 2025 | Perclot |
| Rochester Medical Corporation | $45.83 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $30.60 | 2024 | Bard Urinary Drainage Bag |
| 180 Medical, INC. | $25.12 | 2022 | |
| Rigicon,INC. | $23.06 | 2024 | Rigi10 Malleable Penile Prosthesis |
| Pfizer INC. | $16.99 | 2025 | |
| Becton, Dickinson and Company | $15.70 | 2022 | |
| Integra Lifesciences Corporation | $15.15 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Inouye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.